Rosenblatt Maintains Buy on Imax, Raises Price Target to $30
Portfolio Pulse from richadhand@benzinga.com
Rosenblatt analyst Steve Frankel maintains a 'Buy' rating on Imax (NYSE:IMAX) and raises the price target from $27 to $30.
July 27, 2023 | 11:07 am
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Rosenblatt analyst maintains a 'Buy' rating on Imax and raises the price target from $27 to $30. This could potentially lead to an increase in the stock's price.
The 'Buy' rating maintained by the Rosenblatt analyst and the increase in the price target from $27 to $30 indicates a positive outlook for Imax. This could potentially lead to an increase in the stock's price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100